Polymorphs of 5-fluoro-4-imino-3-methyl-1 -tosyl-3,4-dihydropyrimidin-2-one
US11632954B2 · kind B2 · utility
1Cited by
38References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2018 |
| Grant date | Apr 25, 2023 |
| Priority date | — |
| Expiry date | Jul 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present subject matter provides a crystalline form of the compound having the following structure: wherein the crystalline form is a polymorph, hydrate or solvate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.